Latest Articles
Relugolix in Monotherapy and Combined Therapy for the Treatment of Uterine Diseases and Its Effects on Bones: A Systematic Review.
Background: Uterine fibroids (UFs) and endometriosis are gynecological conditions that significantly increase morbidity among women of reproductive age. Relugolix, a novel gonadotropin-releasing hormone receptor antagonist, is approved in combined therapy …
Published: July 30, 2025, midnight
National endometriosis plan sees no real increase in take-up of treatments - The University of Queensland
National endometriosis plan sees no real increase in take-up of treatments The University of Queensland
Published: July 29, 2025, 10:43 p.m.
Isolated Adenomyosis Linked to Fewer Systemic Comorbidities Compared to Coexisting Endometriosis: Study... - Medical Dialogues
Isolated Adenomyosis Linked to Fewer Systemic Comorbidities Compared to Coexisting Endometriosis: Study... Medical Dialogues
Published: July 29, 2025, 3 p.m.
A new generation test can find traces of endometriosis in menstrual blood - evidencenetwork.ca
A new generation test can find traces of endometriosis in menstrual blood evidencenetwork.ca
Published: July 29, 2025, 11:36 a.m.
Universal Quantum partners with Open Quantum Institute to tackle endometriosis with new technology - Pharmafile
Universal Quantum partners with Open Quantum Institute to tackle endometriosis with new technology Pharmafile
Published: July 29, 2025, 10:28 a.m.
MedEthix was recognized at the Healthcare Asia Pharma awards for its MedEthix Endometriosis Masterclass - Inquirer.net
MedEthix was recognized at the Healthcare Asia Pharma awards for its MedEthix Endometriosis Masterclass Inquirer.net
Published: July 29, 2025, 10:07 a.m.
Endometriosis Rates Increasing Across All Ages, Most Common in Women 35–49 - Epic Research
Endometriosis Rates Increasing Across All Ages, Most Common in Women 35–49 Epic Research
Published: July 29, 2025, 9:44 a.m.
UHNM awarded £250,000 in government funding to launch pioneering endometriosis trial - University Hospitals of North Midlands
UHNM awarded £250,000 in government funding to launch pioneering endometriosis trial University Hospitals of North Midlands
Published: July 29, 2025, 9:42 a.m.
A smile, though endometriosis is no laughing matter - Merimbula News Weekly
A smile, though endometriosis is no laughing matter Merimbula News Weekly
Published: July 29, 2025, 8:16 a.m.
A smile, though endometriosis is no laughing matter - The Canberra Times
A smile, though endometriosis is no laughing matter The Canberra Times
Published: July 29, 2025, 8:13 a.m.
Link copied to clipboard!